Epicardial Adipose Tissue-Targeted DApagliflozin for Reducing Electrical Remodeling in Atrial Fibrillation
Clinical trial NCT07331727 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07331727
- Sponsor
- Shanghai Chest Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2026-09-30
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.